Though mounting evidence has been shown that integrin-mediated cellular adhesion confers resistance to chemotherapy of multiple myeloma, our gene-expression profiling results didn't show that integrin as well as FAK expression changed. The gene discussed is PTK2; the disease is AL amyloidosis.